CPI-601

N/A

Report date: 2025/01/26 16:22:04

Base Information

Drug NameCPI-601
Drug Alias Namerecombinant human palmitoyl-protein thioesterase-1 (Collaborations Pharmaceuticals)CPI-601
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme
Mechanisms of ActionPalmitoyl-protein thioesterase 1 stimulants
TargetsPalmitoyl-protein thioesterase 1
Therapy Area/IndicationsNeuronal Ceroid-Lipofuscinoses
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCollaborations Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesCollaborations Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsNeuronal Ceroid-Lipofuscinoses
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A